Tm Bioscience Licenses Intellectual Property From Abbott
News Oct 04, 2005
Tm Bioscience Corporation has announced that it has concluded a license agreement with Abbott for certain intellectual property in the areas of, among others, human and pathogen genotyping.
The non-exclusive license is worldwide, expires co-terminously with the associated patents and covers Tm's current and future products in all fields of use.
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to pinpoint the ailment's cause and develop a potential and desperately needed nanoparticle-based treatment.READ MORE